top of page
Nelson Advisors > HealthTech & MedTech Thought Leadership


Nelson Advisors interviewed by HSJ for the Expert Briefing story 'The Ambient Voice Technology will hear you now'
Lloyd Price, partner at HealthTech M&A firm Nelson Advisors, said the London results were encouraging on that front also. He said: “One of the biggest takeaways from the GOSH trial is the high level of public comfort and consent rate to using ambient voice technologies. To generate all of the productivity and efficiency gains, patients/carers/parents need to agree to being recorded and transcribed.
Without high levels of public trust, technology solutions will struggle to be
Sep 103 min read
bottom of page